Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatography
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-11-15
著者
-
IWATSUBO Takafumi
Drug Metabolism Laboratories, Institute for Drug Development Research, Yamanouchi Pharmaceutical Co.
-
Aoki Toshiko
Astellas Research Technologies Co. Ltd.
-
Kamimura Hidetaka
Drug Metabolism Research Laboratories Astellas Pharma Inc.
-
Kamimura Hidetaka
Drug Metabolism Department Product Development Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
YANAGIHARA Takamitsu
Drug Metabolism Research Laboratories, Astellas Pharma Inc.
-
SOEISHI Yoshiaki
Astellas Research Technologies Co., Ltd.
-
Iwatsubo Takafumi
Drug Metabolism Research Laboratories Astellas Pharma Inc.
-
Yanagihara Takamitsu
Drug Metabolism Research Laboratories Astellas Pharma Inc.
-
Soeishi Yoshiaki
Astellas Research Technologies Co. Ltd.
-
Iwatsubo Takafumi
Drug Metabolism Res. Laboratories Astellas Pharma Inc.
関連論文
- ヒト薬物動態関連遺伝子の発現に対するHNF4αの寄与をsiRNA発現アデノウイルスを用いて解析する
- Application of LC-NMR for Characterization of Rat Urinary Metabolites of Zonampanel Monohydrate (YM872)
- Quantitative Prediction of In Vivo Drug-drug Interactions from In Vitro Data : Effects of Active Transport of Inhibitors into the Liver
- Assessment of Chimeric Mice with Humanized Liver as a Tool for Predicting Circulating Human Metabolites
- Highly sensitive method for the determination of tamsulosin hydrochloride in human plasma dialysate, plasma and urine by high-performance liquid chromatography-electrospray tandem mass spectrometry
- Pharmacokinetics and Metabolism of an α,β-Blocker, Amosulalol Hydrochloride, in Mice : Biliary Excretion of Carbamoyl Glucuronide(Biopharmacy)
- α-GLUCOSIDE FORMATION in vitro
- Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatography
- Identification of Enzymes Responsible for the N-Oxidation of Darexaban Glucuronide, the Pharmacologically Active Metabolite of Darexaban, and the Glucuronidation of Darexaban N-Oxides in Human Liver Microsomes